HomeLatest NewsQuality NewsFDA approves new flu treatment

FDA approves new flu treatment

The Food and Drug Administration (FDA) has approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. “This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical,” said FDA Commissioner Scott Gottlieb, MD.

Stay Connected

Unified Voice Newsletter

Events This Month

april

16aprAll Day182024 OneLab Summit

16apr9:00 am10:00 amPalliative Care & Advance Care PlanningSDAHO Webinar

16apr11:00 am12:00 pmIncreasing Revenue and Patient SatisfactionAblePay Webinar

16apr11:00 am1:30 pmLiving with Grief: Diagnosis: Prolonged Grief Disorder (member only webinar)SDAHO Webinar

17apr12:00 pm12:45 pmUnite Against Sepsis: Collaborating to Reduce Sepsis Mortality and Improve Care CoordinationTelligen QI Connect


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact